Peter Diamandis - 10 Feb 2023 Form 4 Insider Report for Celularity Inc (CELU)

Role
Director
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
Issuer symbol
CELU
Transactions as of
10 Feb 2023
Transactions value $
$299,880
Form type
4
Filing time
14 Feb 2023, 18:24:13 UTC
Previous filing
09 Aug 2022
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Options Exercise $299,880 +1,071,000 +29.63% $0.28 1,107,145 10 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option (Right to Buy) Options Exercise $0 -1,071,000 -28.7% $0 2,660,136 10 Feb 2023 Class A Common Stock 1,071,000 $0.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 36,145 shares underlying restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
F2 This option is fully vested and exercisable.